Wells Fargo & Company Viatris Inc Call Options Transaction History

Wells Fargo & Company

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $3 Million - $4.1 Million	221,100 Added 658.04%	254,700 $3.56 Million
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $480,480 - $629,664	33,600 New	33,600 $47,000

1,091

971M

2.63M

2.15M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.